Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg.
Re
Richard
R
Research Division, Ochsner Clinic Foundation, New Orleans, LA 70121, USA. rre@ochsner.org
D008841:Actin Cytoskeleton / Q000378:metabolism; D021581:Active Transport, Cell Nucleus; D000804:Angiotensin II / Q000096:biosynthesis*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D000808:Angiotensinogen / Q000096:biosynthesis; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology; D001713:Biphenyl Compounds; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism*; D053818:Chymases / Q000096:biosynthesis; D003593:Cytoplasm / Q000378:metabolism; D005110:Extracellular Space / Q000378:metabolism; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D051381:Rats; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism*; D012083:Renin / Q000096:biosynthesis; D012084:Renin-Angiotensin System / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology; D013777:Tetrazoles / Q000494:pharmacology
D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D044140:Receptor, Angiotensin, Type 1; D013566:Sympathomimetics; D013777:Tetrazoles; D000808:Angiotensinogen; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D053818:Chymases; D012083:Renin; D005947:Glucose; D007545:Isoproterenol; C081643:candesartan